NCT03839381 Turkish Version of Mini-BESTest, Validity and Reliability for Adult Participants With Sensoriomotor Impairments Status UNKNOWN Phase N/A
NCT03829267 eFIT: An Internet-based Intervention to Increase Physical Activity in Persons With MS Status COMPLETED Phase NA
NCT03825601 PET with [18F]Flumazenil As an Index of Neurodegeneration in MS Status COMPLETED Phase NA
NCT03825055 Resilience in Young Adults Newly Diagnosed With Multiple Sclerosis Status COMPLETED Phase N/A
NCT03822858 Expanded Access to Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Progressive Multiple Sclerosis Status AVAILABLE Phase N/A
NCT03816345 Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO Status RECRUITING Phase PHASE1
NCT03808545 Activity and Balanced Eating to Reduce Comorbidities and Symptoms of MS Status TERMINATED Phase NA
NCT03808142 PROmyBETAappGame: a Study to Learn More About the Medication Usage & Patient Reported Outcomes Via the myBETAapp and to Find Out More About the Usage of Game Principles and Game Design Elements (Gamification) in Medical Care of Patients With Multiple Sclerosis Treated With Betaferon Status COMPLETED Phase N/A
NCT03807973 Tracking Peripheral Immune Cell Infiltration of the Brain in Central Inflammatory Disorders Using [Zr-89]Oxinate-4-labeled Leukocytes. Status SUSPENDED Phase PHASE1
NCT03806387 Physical and Cognitive Performance During the Two First Years of Lemtrada Treatment Status COMPLETED Phase N/A
NCT03805061 Effects of Aerobic and Isokinetic Exercise in Multiple Sclerosis Status COMPLETED Phase NA
NCT03804047 KITAMS: Kinesio Tape and Physical Function in Persons With Multiples Sclerosis Status UNKNOWN Phase NA
NCT03803800 Periodized Rehabilitation and Beta-alanine Supplementation in Multiple Sclerosis Status COMPLETED Phase NA
NCT03801473 Comparison of Robot-Assisted Gait Training and Conventional Therapy in Multiple Sclerosis Patients Status COMPLETED Phase NA
NCT03797937 Microbiome Benchmarking to Identify Perturbations in Multiple Sclerosis II Status COMPLETED Phase NA